Soin Neuroscience
http://www.soinneuroscience.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Soin Neuroscience
Parkinson’s Disease: Novel Science And Collaborations Fuel Progress
Novel therapeutic strategies for Parkinson’s disease have brought a renewed sense of optimism to those researching this neurodegenerative disorder. Numerous treatment avenues are being explored, including small molecules, gene therapy, cell therapy and medical devices to stimulate nerves deep in the brain. Digital also gets a look-in, being useful for analyzing gait and other symptoms, and addressing both mental and physical issues.
Cleveland Clinic Innovations – Creating A Global Innovation Engine
At a time when venture capital dollars are scarce and US-based innovation is threatened, Cleveland Clinic Innovations, with its novel GCIC cardiovascular project, is bringing critical mass and a new direction to an inherently unwieldy process.
Recent Tech Transfer Deals, June 2012
START-UP’s monthly update on technology transfer deals—licensing agreements between companies and universities or other research institutions—in the fields of in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
Selected Start-Ups (10/2010)
In Vivo briefly describes these recently founded companies: Annovation BioPharma, BioMatrx, Dermadis, Lantos Technologies, Pulsar Vascular and TheraVasc.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Soin Therapeutics Inc.
- TheraVasc, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice